SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast 
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
Meta Expands AI Training With Employee Activity Tracking Tools 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
BRIGHTON, Colo., March 19, 2017 -- Brighton Eye Associates is pleased to announce to the community the introduction of the High Definition CIRRUS HD-OCT technology as part of an enhanced eye examination. The Ocular Coherence Tomography or OCT provides a microscopic 3-D evaluation of the eye. Especially important is its use for macular degeneration and for glaucoma. It is also valuable for other eye conditions including diabetes and high blood pressure. Doctors are able to see the difference between wet macular degeneration and dry macular degeneration.
Glaucoma is usually seen in people over the age of 40. People do not know they have glaucoma because it has no symptoms. Early detection, monitoring, and treatment slows the progress of glaucoma. The new High Definition CIRRUS HD-OCT instrument allows for a 3D examination of the eye and much earlier diagnosis of glaucoma.
“We are excited to offer the new HD OCT instrument to our patients,” said Dr. Rodney D. Fair, OD. “Dr. Baker, Dr. Sanchez and I are always looking for better ways to serve the vision needs of our patients and this instrument is the latest addition to our state-of-the-art technology used to help our patients at Brighton Eye Associates.”
Visit http://brightoneye.net/ for more details.
Brighton Eye Associates 1001 E. Bridge Street Brighton, CO 80601 (303) 659-3036
